Magnus Doverskog,Hanns Möhler,Vicente Felipo,Torbjörn Bäckström
申请号:
US15716838
公开号:
US20180015103A1
申请日:
2017.09.27
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides the steroidal compound 3α-ethynyl-3β-hydroxyandrostan-17-one oxime, or a pharmaceutically acceptable salt thereof, for use in treatment of hepatic encephalopathy.